Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · Real-Time Price · USD
14.19
+0.07 (0.50%)
Nov 13, 2024, 4:00 PM EST - Market closed
Elanco Animal Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Revenue | 4,454 | 4,417 | 4,411 | 4,764 | 3,271 | 3,071 | Upgrade
|
| Revenue Growth (YoY) | 1.99% | 0.14% | -7.41% | 45.64% | 6.51% | 0.14% | Upgrade
|
| Cost of Revenue | 2,016 | 1,929 | 1,913 | 2,068 | 1,577 | 1,469 | Upgrade
|
| Gross Profit | 2,438 | 2,488 | 2,498 | 2,696 | 1,694 | 1,602 | Upgrade
|
| Selling, General & Admin | 1,301 | 1,280 | 1,259 | 1,395 | 988 | 757 | Upgrade
|
| Research & Development | 342 | 327 | 321 | 369 | 329 | 270 | Upgrade
|
| Operating Expenses | 2,178 | 2,155 | 2,108 | 2,320 | 1,677 | 1,227 | Upgrade
|
| Operating Income | 260 | 333 | 390 | 376 | 17 | 375 | Upgrade
|
| Interest Expense | -256 | -277 | -241 | -236 | -150 | -79 | Upgrade
|
| Currency Exchange Gain (Loss) | -41 | -40 | -38 | -35 | -4 | 5 | Upgrade
|
| Other Non Operating Income (Expenses) | 42.5 | -2.5 | - | 22 | -60 | -28 | Upgrade
|
| EBT Excluding Unusual Items | 5.5 | 13.5 | 111 | 127 | -197 | 273 | Upgrade
|
| Merger & Restructuring Charges | -71 | -95 | -98 | -336 | -702 | -187 | Upgrade
|
| Impairment of Goodwill | - | -1,042 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | 11 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 640 | - | - | - | 211 | - | Upgrade
|
| Asset Writedown | -103 | -32 | -81 | - | - | - | Upgrade
|
| Legal Settlements | -42.5 | -27.5 | - | -10 | - | - | Upgrade
|
| Other Unusual Items | -17 | -12 | -4 | -352 | - | -8 | Upgrade
|
| Pretax Income | 412 | -1,195 | -72 | -571 | -677 | 78 | Upgrade
|
| Income Tax Expense | 207 | 36 | 6 | -88 | -103 | 10 | Upgrade
|
| Net Income | 205 | -1,231 | -78 | -483 | -574 | 68 | Upgrade
|
| Net Income to Common | 205 | -1,231 | -78 | -483 | -574 | 68 | Upgrade
|
| Net Income Growth | - | - | - | - | - | -21.39% | Upgrade
|
| Shares Outstanding (Basic) | 494 | 492 | 488 | 487 | 441 | 369 | Upgrade
|
| Shares Outstanding (Diluted) | 496 | 492 | 488 | 487 | 441 | 370 | Upgrade
|
| Shares Change (YoY) | 0.97% | 0.82% | 0.23% | 10.38% | 19.20% | 18.04% | Upgrade
|
| EPS (Basic) | 0.42 | -2.50 | -0.16 | -0.99 | -1.30 | 0.18 | Upgrade
|
| EPS (Diluted) | 0.41 | -2.50 | -0.16 | -0.99 | -1.30 | 0.18 | Upgrade
|
| EPS Growth | - | - | - | - | - | -34.72% | Upgrade
|
| Free Cash Flow | 380 | 131 | 281 | 324 | -176 | 84 | Upgrade
|
| Free Cash Flow Per Share | 0.77 | 0.27 | 0.58 | 0.67 | -0.40 | 0.23 | Upgrade
|
| Gross Margin | 54.74% | 56.33% | 56.63% | 56.59% | 51.79% | 52.17% | Upgrade
|
| Operating Margin | 5.84% | 7.54% | 8.84% | 7.89% | 0.52% | 12.21% | Upgrade
|
| Profit Margin | 4.60% | -27.87% | -1.77% | -10.14% | -17.55% | 2.21% | Upgrade
|
| Free Cash Flow Margin | 8.53% | 2.97% | 6.37% | 6.80% | -5.38% | 2.74% | Upgrade
|
| EBITDA | 875 | 973 | 1,007 | 1,040 | 499 | 669 | Upgrade
|
| EBITDA Margin | 19.65% | 22.03% | 22.83% | 21.83% | 15.26% | 21.78% | Upgrade
|
| D&A For EBITDA | 615 | 640 | 617 | 664 | 482 | 294 | Upgrade
|
| EBIT | 260 | 333 | 390 | 376 | 17 | 375 | Upgrade
|
| EBIT Margin | 5.84% | 7.54% | 8.84% | 7.89% | 0.52% | 12.21% | Upgrade
|
| Effective Tax Rate | 50.24% | - | - | - | - | 12.82% | Upgrade
|
| Advertising Expenses | - | 207 | 201 | 248 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.